Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | CES2 | O00748 | 2/20 | 0.46 |
| ▸ | CES1 | P23141 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5325112 | 0.80 | CA1 (0.59) | HPGDCES2CES1TSHRALOX15 | |
| SCHEMBL24704036 | 0.79 | TSHR (0.56) | HPGDCES2CES1TSHRALOX15 | |
| SCHEMBL2706993 | 0.79 | CES2 (0.62) | HPGDCES2CES1TSHRL3MBTL1 | |
| SCHEMBL19309855 | 0.76 | ALDH1A1 (0.49) | HPGDCES2CES1TSHRL3MBTL1 | |
| SCHEMBL191087 | 0.76 | HPGD (0.48) | HPGDCES2CES1TSHRL3MBTL1 | |
| SCHEMBL5917997 | 0.74 | HPGD (0.47) | HPGDCES2CES1TSHRL3MBTL1 | |
| SCHEMBL27672036 | 0.74 | HPGD (0.47) | HPGDCES2CES1TSHRL3MBTL1 | |
| SCHEMBL196916 | 0.74 | CA1 (0.64) | HPGDCES2CES1TSHRL3MBTL1 | |
| SCHEMBL5320832 | 0.74 | TSHR (0.58) | CES2CES1TSHRL3MBTL1ALOX15 | |
| SCHEMBL6025903 | 0.73 | ERCC5 (0.65) | HPGDL3MBTL1ALDH1A1KDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10385213-B2 | Candle wax compositions stabilized with UV absorbers and select hindered amine light stabilizers | BASF SE (DE) | 2019-08-20 | — | — | US | disclosed |
| US-20180002527-A1 | CANDLE WAX COMPOSITIONS STABILIZED WITH UV ABSORBERS AND SELECT HINDERED AMINE LIGHT STABILIZERS | BASF SE (DE) | 2018-01-04 | — | — | US | disclosed |
| WO-2016109789-A1 | CANDLE WAX COMPOSITIONS STABILIZED WITH UV ABSORBERS AND SELECT HINDERED AMINE LIGHT STABILIZERS | BASF SE (DE) | 2016-07-07 | — | — | WO | disclosed |
| US-20070256352-A1 | Substituted hexahydro-1,4-diazepin-5-ones and compositions stabilized therewith | WOOD MERVIN G | 2007-11-08 | — | — | US | disclosed |
| US-6905525-B2 | Candle wax stabilized with piperazinones | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2005-06-14 | — | — | US | disclosed |
| EP-1252227-B1 | CANDLE WAX STABILIZED BY A COMBINATION OF UV ABSORBER PLUS A SELECTED HINDERED AMINE | CIBA SC HOLDING AG (CH) | 2004-09-22 | — | — | EP | disclosed |
| EP-1383832-A1 | STABILIZED CANDLE WAX | Ciba SC Holding AG (CH) | 2004-01-28 | — | — | EP | disclosed |
| US-6562084-B2 | Against discoloration and fading; also a UV absorber and/or an antioxidant | CIBA SPECIALTY CHEMICALS CORPORATION | 2003-05-13 | — | — | US | disclosed |
| US-6547840-B2 | White, dyed, dipped, unscented and/or scented candle wax is effectively stabilized against discoloration and fading by the incorporation of an imidazolidine in combination with a UV absorber and/or an antioxidant | CIBA SPECIALTY CHEMICALS CORPORATION | 2003-04-15 | — | — | US | disclosed |
| US-6544304-B2 | White, dyed, dipped, unscented and/or scented candle wax stabilized against discoloration/fading by a morpholinone, e.g., 2,3,3,4,5,5-hexamethylmorpholin-2-one; including an ultra-violet absorber; oxidation resistance | CIBA SPECIALTY CHEMICALS CORPORATION | 2003-04-08 | — | — | US | disclosed |
| US-20030051392-A1 | CANDLE WAX STABILIZED WITH PIPERAZINDIONES | CIBA SPECIALTY CHEMICALS CORP. | 2003-03-20 | — | — | US | disclosed |
| US-20030005621-A1 | Candle wax stabilized with morpholinones | CIBA SPECIALTY CHEMICALS CORP. | 2003-01-09 | — | — | US | disclosed |
| US-20030000128-A1 | Candle wax stabilized with oxazolidines | CIBA SPECIALTY CHEMICALS CORP. | 2003-01-02 | — | — | US | disclosed |
| US-20030000130-A1 | Candle wax stabilized with piperazinones | CIBA SPECIALITY CHEMICALS CORP. | 2003-01-02 | — | — | US | disclosed |
| US-20020194776-A1 | Candle wax stabilized with imidazolidines | CIBA SPECIALTY CHEMICALS CORP. | 2002-12-26 | — | — | US | disclosed |
| US-20020194777-A1 | Candle wax stabilized with piperazinones | CIBA SPECIALTY CHEMICALS CORP. | 2002-12-26 | — | — | US | disclosed |
| EP-1252227-A1 | CANDLE WAX STABILIZED BY A COMBINATION OF UV ABSORBER PLUS A SELECTED HINDERED AMINE | Ciba SC Holding AG (CH) | 2002-10-30 | — | — | EP | disclosed |
| WO-2002079313-A1 | STABILIZED CANDLE WAX | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2002-10-10 | — | — | WO | disclosed |
| WO-2001057126-A1 | CANDLE WAX STABILIZED BY A COMBINATION OF UV ABSORBER PLUS A SELECTED HINDERED AMINE | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2001-08-09 | — | — | WO | disclosed |
| US-6221115-B1 | WHITE, DYED, DIPPED, UNSCENTED AND/OR SCENTED CANDLE WAX STABILIZED BY A ULTRAVILET RADIATION ABSORBER AND HINDERED AMINE STABILIZING AGENT | CIBA SPECIALTY CHEMICALS CORPORATION | 2001-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070256352-A1 | Substituted hexahydro-1,4-diazepin-5-ones and compositions stabilized therewith | CRY1, GPX4, CAND1 | HPGD 847/4885CES2 930/4885CES1 866/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.